Market Overview:
Global Molecular Diagnostics Market size was valued at USD 14.00 billion in 2022 and is poised to grow from USD 15.60 billion in 2023 to USD 37.00 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031). Global molecular diagnostics market offers great potential for growth owing to the technological progress, development of new technologies, the growth of the number of cases of infectious diseases, and the utilization of individualized medicine. Molecular diagnostics includes detection and characterization of disease biomolecules ranging from genetic markers, proteins, and other analytes. This market is extensive, and it covers areas such as infectious diseases, oncology, genetic disorders, pharmacogenomics and many more.
Market Insights:
Molecular Diagnostics Market Drivers
Technological Advancements is Boosting the Market Growth
The PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), and microarray technologies have developed rapidly and evolved the entire molecular diagnostic technology, thus contributing to the enhanced market. Advancements in this diagnostic equipment have continued to develop better accuracy, sensitivity and speed thus contributing to market expansion.
Increasing Prevalence of Infectious Diseases and Genetic Disorders
There is an increasing incidence of infective diseases, including HIV/Aids, Hepatitis B and C, Tuberculosis and growing occurrence of genetic disorders that has led to the need of molecular diagnostics. PCR and other molecular diagnostic work on pathogens allow accurate and sensitive diagnosis, permits timely management and treatment, and allows delivery of tailored or individualized care.
Download a detailed overview:
https://www.skyquestt.com/sample-request/molecular-diagnostics-market
Key Market Segments:
The global molecular diagnostics market is segmented by Product & Service, Test Type, Sample Type, Technology, Application, End User, and region.
Based on Product & Service, the market is segmented into reagents & kits, instruments, and services & software.
Based on Test Type, the market is segmented into Lab Tests, and PoC Tests.
Based on Sample Type, the market is segmented into Blood, Serum, & Plasma, Urine, and Others.
Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next- Generation Sequencing, In Situ Hybridization, DNA Microarrays, and Others.
Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, COVID-19, and Others.
Based on Infectious Disease, the market is segmented into Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, and Other Infectious Diseases.
Based on Oncology Testing, the market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers.
Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Other End Users.
Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/molecular-diagnostics-market
Analysis by Product & Service
Among the pivotal segments, reagents & kits emerge as the largest contributor, wielding considerable influence over market trends and revenue streams. These fundamental factors contribute to the basic framework of a molecular diagnostic process and are indispensable in identifying and characterizing nucleic acids, proteins, and other molecular markers or biomarkers of different diseases. Due to rapidly increasing incidence of infectious diseases, genetic disorders, cancer around the world, the requirement of reagents and kits are high because of the need of right diagnosis in right time. Additionally, the progress in the biotechnology field and the shift from one-size-fits-all therapies to more individualized treatment promotes this segment, increasing the applicability of molecular diagnostic solutions in various types of healthcare services.
Regional Insights:
North America come up as the largest market and held a 39% share in 2023. This can be attributed to the increasing incidence of both infectious and chronic diseases; such trends make companies develop new molecular diagnostic tests to help drive the market further. For instance, in August 2023, QIAGEN recently got approval through the U. S FDA for Thera screen PDGFRA RGQ PCR kit; this helps physicians identify patients with gastrointestinal stromal tumor (GIST). In addition, in the year of January 2023, the FDA has granted EUA for the VIASURE Monkeypox Virus Real-Time PCR Reagents manufactured by BD and CerTest Biotec for identifying the Mpox virus. In addition, increased consumer awareness and health consciousness, high standards of living and specifically, well developed healthcare infrastructure can be said to be the factors that are driving this growth.
It is also expected that the Asia-Pacific region will have the fastest growing region rate during the forecast period because of better market access, joint market player efforts to encourage more of the diagnostic market, and the huge unmet demands in the Asia – Pacific region for diagnostic markets. For instance, in August 2023 CRISPRBits and MolBio Diagnostics Indians companies signed a strategic partnership to fast change the POC diagnostics to integrate the CRISPR system in both a POC test for pathogen and genetic markers’ identification. Additionally, the increase in Next-generation sequencing (NGS), the awareness of life-threatening diseases such as Cancer, Covid-19, Tuberculosis, STDs, the trend towards more personalised medicine, and the use of Artificial intelligence & Machine learning explains the regional market expansion.
Prominent Players in Molecular Diagnostics Market:
- Hoffmann-La Roche Ltd. (Switzerland)
- Hologic, Inc. (US)
- Abbott Laboratories (US)
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- bioMérieux (France)
- QIAGEN (Netherlands)
- Agilent Technologies Inc. (US)
- Becton Dickinson And Company (US)
- Grifols S.A. (Spain)
- Siemens AG (Siemens Healthineers) (Germany)
- Bio-Rad Laboratories, Inc. (US)
- Sysmex Corporation (Japan)
- Quidel Corporation (US)
- Biocartis (Belgium)
- DiaSorin (Italy)
- Myriad Genetics (US)
- Revvity (US)
- MDxHealth (Belgium)
- OncoCyte Corporation (US)
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/molecular-diagnostics-market
Additional Insights:
Market Penetration: Analysis of the product portfolio of different market players and the status of new product launches.
Product Development/Innovation: Assessment of R&D activities, new product development, and emerging trends.
Market Development: Analysis of regions with high growth potential.
Market Diversification: Assessment of new products, recent developments, and emerging regional markets.
Competitive Landscape: Growth strategies, revenue analysis, and product innovations by market players.
Key Questions Answered in Molecular Diagnostics Market Report:
What is the global market size of the Molecular Diagnostics Market?
Who are the key vendors in the Molecular Diagnostics Market?
What is the key driver of the Molecular Diagnostics Market?
What is the key market trend for the Molecular Diagnostics Market?
Which region accounted for the largest share in the Molecular Diagnostics Market?
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: [email protected]
Visit Our Website: https://www.skyquestt.com/
